Literature DB >> 18289203

Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.

Megan M Garrity-Park1, Edward V Loftus, Sandra C Bryant, William J Sandborn, Thomas C Smyrk.   

Abstract

OBJECTIVES: Ulcerative colitis (UC) is characterized by chronic recurrent mucosal inflammation. Genetic studies in UC have indicated linkage to chromosome 6 in the region of the tumor necrosis factor-alpha (TNF-alpha) gene, a potent proinflammatory cytokine. TNF-alpha production is influenced by multiple factors including the type of immune cell and its level of activation. However, several single nucleotide polymorphisms (SNP) in the promoter region of TNF-alpha have been correlated with either increased or decreased production, indicating that regulation of TNF-alpha is in part genetic. Because UC patients are at increased risk for developing colorectal cancer (CRC), we investigated if there was an association between SNPs in the promoter of the TNF-alpha gene and UC-CRC.
METHODS: DNA was extracted from formalin-fixed, paraffin-embedded tissue from 114 UC-CRC cases and 114 UC-no CRC controls. Controls were frequency matched on duration and extent of colitis, age, ethnicity, and gender. All 228 tissue samples were analyzed for five TNF-alpha promoter polymorphisms (-238[G-->A], -308[G-->A], -857[C-->T], -863[C-->A], and -1031[T-->C]) using PCR and sequencing.
RESULTS: The -308(G-->A) SNP was significantly associated with UC-CRC cases at both the allele and genotype level (P < 0.0001). No other SNPs were significantly associated with UC-CRC.
CONCLUSION: We report a novel finding of a strong association between the -308(G-->A) SNP and UC-CRC. Complete elucidation of the mechanism of UC-CRC carcinogenesis will require investigation of other genes involved in modulating inflammation, but our results suggest that some UC patients may have additional genetic predispositions toward developing UC-CRC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18289203     DOI: 10.1111/j.1572-0241.2007.01572.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  21 in total

Review 1.  Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.

Authors:  Peter-Laszlo Lakatos; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

2.  The tumor necrosis factor-α-238 polymorphism and digestive system cancer risk: a meta-analysis.

Authors:  Ming Hui; Xiaojuan Yan; Ying Jiang
Journal:  Clin Exp Med       Date:  2015-06-06       Impact factor: 3.984

Review 3.  TNF-α-308 polymorphism and risk of digestive system cancers: a meta-analysis.

Authors:  Xu-Feng Guo; Jun Wang; Shi-Jie Yu; Jia Song; Meng-Yao Ji; Zhuo Cao; Ji-Xiang Zhang; Jing Wang; Wei-Guo Dong
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 4.  A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.

Authors:  Ian S Reynolds; Aobhlinn O'Toole; Joseph Deasy; Deborah A McNamara; John P Burke
Journal:  Int J Colorectal Dis       Date:  2017-01-11       Impact factor: 2.571

Review 5.  Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.

Authors:  H Li; Z Jin; X Li; L Wu; J Jin
Journal:  Clin Transl Oncol       Date:  2017-02-27       Impact factor: 3.405

Review 6.  Tumor necrosis factor and cancer, buddies or foes?

Authors:  Xia Wang; Yong Lin
Journal:  Acta Pharmacol Sin       Date:  2008-11       Impact factor: 6.150

7.  A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.

Authors:  Shuji Ogino; Katsuhiko Nosho; Yoshifumi Baba; Shoko Kure; Kaori Shima; Natsumi Irahara; Saori Toyoda; Li Chen; Gregory J Kirkner; Brian M Wolpin; Andrew T Chan; Edward L Giovannucci; Charles S Fuchs
Journal:  Am J Gastroenterol       Date:  2009-06-09       Impact factor: 10.864

8.  Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.

Authors:  J B Kisiel; T C Yab; F T Nazer Hussain; W R Taylor; M M Garrity-Park; W J Sandborn; E V Loftus; B G Wolff; T C Smyrk; S H Itzkowitz; D T Rubin; H Zou; D W Mahoney; D A Ahlquist
Journal:  Aliment Pharmacol Ther       Date:  2013-01-24       Impact factor: 8.171

Review 9.  Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.

Authors:  Linda A Feagins; Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

10.  Bacterial infection of Smad3/Rag2 double-null mice with transforming growth factor-beta dysregulation as a model for studying inflammation-associated colon cancer.

Authors:  Lillian Maggio-Price; Piper Treuting; Helle Bielefeldt-Ohmann; Audrey Seamons; Rolf Drivdahl; Weiping Zeng; LapHin Lai; Mark Huycke; Susan Phelps; Thea Brabb; Brian M Iritani
Journal:  Am J Pathol       Date:  2009-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.